Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
2020 · Molecular Therapy · 55 citations
https://doi.org/10.1016/j.ymthe.2020.07.017
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
169
Citations
3
h-index
3
i10-index
Evan Tooker is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Phagocytosis and Immune Regulation. The author has an h-index of 3, co-authored 18 publications.
Click to start Chat